Literature DB >> 1748979

Prognostic factors in dogs with lymphoma and associated hypercalcemia.

M P Rosenberg1, R E Matus, A K Patnaik.   

Abstract

Lymphoma and hypercalcemia were diagnosed in 37 dogs. Twenty-six of the dogs received chemotherapy. The association between some prognostic factors including clinical stage of disease, illness status, presence of bone marrow involvement, and presence of an anterior mediastinal mass and remission duration and survival time was evaluated. Statistical analysis of the prognostic factors showed that the presence of an anterior mediastinal mass had an adverse effect on remission duration (P less than 0.03). Calcium concentration was not significantly related to any of the prognostic factors evaluated. Dogs that received chemotherapy were more likely to be self-supporting than the dogs that were not treated (P less than 0.005). However, initial illness status was not significantly related to remission duration or survival time in the 26 dogs that were treated. Six dogs (25% of dogs treated) survived longer than 14 months. Five of these dogs were female. Overall mean and median remission times were 10.4 and 6 months, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748979     DOI: 10.1111/j.1939-1676.1991.tb03133.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  5 in total

1.  Patient characteristics, prognostic factors and outcome of dogs with high-grade primary mediastinal lymphoma.

Authors:  E L Moore; W Vernau; R B Rebhun; K A Skorupski; J H Burton
Journal:  Vet Comp Oncol       Date:  2017-06-28       Impact factor: 2.613

2.  Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.

Authors:  Cecile T Siedlecki; Philip H Kass; Martin J Jakubiak; Gillian Dank; Jarred Lyons; Michael S Kent
Journal:  Can Vet J       Date:  2006-01       Impact factor: 1.008

3.  Alimentary lymphosarcoma in a 4-year-old Labrador retriever.

Authors:  Andrew D Lowe
Journal:  Can Vet J       Date:  2004-07       Impact factor: 1.008

4.  Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma.

Authors:  Joseph A Impellizeri; Alessandra Gavazza; Eliana Greissworth; Anna Crispo; Maurizio Montella; Gennaro Ciliberto; George Lubas; Luigi Aurisicchio
Journal:  J Transl Med       Date:  2018-12-11       Impact factor: 5.531

5.  Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.

Authors:  A Koshino; Y Goto-Koshino; A Setoguchi; K Ohno; H Tsujimoto
Journal:  J Vet Intern Med       Date:  2015-12-17       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.